首页|新冠病毒疫苗序贯免疫策略研究进展

新冠病毒疫苗序贯免疫策略研究进展

扫码查看
新型冠状病毒感染疫情(简称新冠疫情)的大流行,给全球生命安全和经济发展造成了严重影响.接种新型冠状病毒疫苗(简称新冠病毒疫苗)是预防新型冠状病毒(severe acute respiratory syndrome coronavirus2,SARS-CoV-2)感染、降低其发病率和重症率的重要措施.目前全球共有6种不同技术路线的新冠病毒疫苗,即蛋白亚单位疫苗、核酸疫苗(mRNA疫苗和DNA疫苗)、病毒载体疫苗、灭活疫苗、病毒样颗粒疫苗、减毒活疫苗.序贯免疫策略是将不同技术路线的新冠病毒疫苗按照一定时间间隔、剂次完成接种,是解决疫苗短缺、应对病毒突变株、提高疫苗效力的有效策略,国内外很多学者开展了新冠病毒疫苗的序贯免疫策略研究.本文从新冠病毒灭活疫苗与mRNA疫苗、与腺病毒载体疫苗、与蛋白亚单位疫苗的序贯免疫策略及新冠病毒腺病毒载体疫苗与mRNA疫苗、与蛋白亚单位疫苗的序贯免疫策略5个方面对国内外新冠病毒疫苗序贯免疫策略的相关研究进行了概述,以期为新冠病毒疫苗的接种和免疫策略的制定提供参考依据.
Research progress on sequential immunization strategies of COVID-19 vaccines:a review
The global pandemic of the coronavirus disease 2019(COVID-19)has had a serious impact on global life safety and economic development.Vaccination with the coronavirus disease vaccine(COVID-19 vaccine)is an important measure to prevent infection,reduce the incidence and severity of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2).Currently,there are six different technological routes for COVID-19 vaccines worldwide,including protein subunit vaccines,nucleic acid vaccines(mRNA vaccines and DNA vaccines),viral vector vaccines,inactivated vaccines,virus-like particle vaccines,and attenuated vaccines.Sequential immunization strategy is a valid approach for solving vaccine shortages,responding to viral variants,and improving vaccine efficacy by administering COVID-19 vaccines of different technological routes at specific time intervals and doses.Many scholars at home and abroad have conducted research on the sequential immunization strategy of COVID-19 vaccines.This article provided an overview of the research on the sequential immunization strategy of COVID-19 vaccines at home and abroad in five aspects:COVID-19 inactivated vaccine and mRNA vaccine,COVID-19 inactivated vaccine and adenovirus vector vaccine,COVID-19 inactivated vaccine and protein subunit vaccine,COVID-19 adenovirus vector vaccine and mRNA vaccine,COVID-19 adenovirus vector vaccine and protein subunit vaccine,aiming to provide reference for the inoculation and formulation of immunization strategies for COVID-19 vaccines.

SARS-CoV-2COVID-19 vaccinesequential immunizationefficacysafety

戴荣荣、张杭杰、蒋健敏

展开 >

杭州医学院公共卫生学院,杭州 310053

浙江省疾病预防控制中心,杭州 311400

新型冠状病毒 新冠病毒疫苗 序贯免疫 有效性 安全性

浙江省重点研发计划应急攻关项目(2021)国家卫生健康委科学研究基金(2022)浙江省自然科学基金(2022)浙江省自然科学基金(2023)

2021C03200WKJ-ZJ-2221D22H190603Q23H100002

2024

中国公共卫生
中华预防医学会

中国公共卫生

CSTPCD北大核心
影响因子:1.404
ISSN:1001-0580
年,卷(期):2024.40(2)
  • 52